DR info

Clinical trials : 13 / Drugs : 14 - (DrugBank : 7) / Drug target genes : 4 - Drug target pathways : 75

Crow-Fukase syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
16	Crow-Fukase syndrome
49	Systemic lupus erythematosus
28	Systemic amyloidosis
331	Idiopathic multicentric castleman disease
26	HTLV-1-associated myelopathy
51	Scleroderma
46	Malignant rheumatoid arthritis
13	Multiple sclerosis/Neuromyelitis optica
38	Stevens-Johnson syndrome
45	Eosinophilic granulomatosis with Polyangiitis
283	Acquired pure red cell aplasia
284	Diamond-Blackfan anemia
35	Pemphigus
40	Takayasu arteritis
61	Autoimmune hemolytic anemia
42	Polyarteritis nodosa
285	Fanconi anemia
41	Giant cell arteritis
228	Bronchiolitis obliterans
164	Oculocutaneous albinism
66	IgA nephropathy
60	Aplastic anemia
11	Myasthenia gravis
63	Idiopathic thrombocytopenic purpura
222	Primary nephrotic syndrome
19	Lysosomal storage disease
65	Primary immunodeficiency
85	Idiopathic interstitial pneumonia
96	Crohn disease
2	Amyotrophic lateral sclerosis
25	Progressive multifocal leukoencephalopathy
39	Toxic epidermal necrolysis
220	Rapidly progressive glomerulonephritis
30	Distal myopathy